Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chiu CC
------>authors3_c=None
------>paper_class1=1
------>Impact_Factor=4.419
------>paper_class3=2
------>paper_class2=4
------>vol=25
------>confirm_bywho=b521073
------>insert_bywho=mongliang
------>Jurnal_Rank=8.9
------>authors4_c=None
------>comm_author=1
------>patent_EDate=None
------>authors5_c=None
------>publish_day=None
------>paper_class2Letter=None
------>page2=627
------>medlineContent=
------>unit=E0120
------>insert_date=20051202
------>iam=2
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=None
------>authors_c=None
------>score=-10000
------>journal_name=Journal of Clinical Psychopharmacology
------>paper_name=Comments on Articles by Albers et al: "Low-Dose Fluvoxamine as an Adjunct to Reduce Olanzapine Therapeutic Dose Requirements: A Prospective Dose-Adjusted Drug Interaction Strategy."
------>confirm_date=20060203
------>tch_id=090001
------>pmid=no found
------>page1=626
------>fullAbstract=no found
------>tmu_sno=None
------>sno=11928
------>authors2=Lu ML
------>authors3=
------>authors4=
------>authors5=
------>authors6=
------>authors6_c=None
------>authors=Chiu CC
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=None
------>publish_area=None
------>updateTitle=no found
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=6
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2005
------>submit_flag=None
------>publish_month=None
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z